NATIONWIDE CHILDRENS HOSPITAL INC has a total of 46 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Australia and Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CALDER BIOSCIENCES INC, HEMOSOL INC and ACADEMISCH ZIEKENHUIS LEIDEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 10 | |
#3 | Japan | 6 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | Brazil | 1 | |
#7 | Chile | 1 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Machines | |
#6 | Foods and drinks | |
#7 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Bakaletz Lauren O | 15 |
#2 | Harper Scott Quenton | 13 |
#3 | Liu Jian | 13 |
#4 | Kaspar Brian K | 8 |
#5 | Wallace Lindsay | 7 |
#6 | Foust Kevin | 7 |
#7 | Munson Robert S Jr | 6 |
#8 | Garwick Sara | 5 |
#9 | Das Subinoy | 4 |
#10 | Dyer David W | 4 |
Publication | Filing date | Title |
---|---|---|
CN110325219A | Encode the intrathecal delivering of the recombinant adeno-associated virus of Methyl-CpG binding proteins 2 | |
EP3350319A1 | Recombinant virus products and methods for inhibition of expression of myotilin | |
US2016310548A1 | Recombinant virus products and methods for inhibition of expression of myotilin | |
AU2013202310A1 | Compositions and methods for the removal of biofilms | |
CA2842798A1 | Recombinant virus products and methods for inhibition of expression of dux4 | |
AU2012268380A1 | Proteomics based diagnostic detection method for chronic sinusitis | |
AU2012203017A1 | Haemophilus Influenzae Type IV Pili | |
AU2004309399A1 | Haemophilus influenzae type IV pili |